photo courtesy of ddpavumba/freedigitalphotos.net

Neurogranin Levels in Cerebrospinal Fluid – A New Addition to the Alzheimer Disease Diagnostic Toolbox

Recent biomarker studies suggest that the pathological changes of Alzheimer disease (AD) start with Aβ deposition as early as 20 to 30 years prior to symptom onset,1 a window of time that holds promise for therapeutic intervention to reverse or slow down the disease. Aβ deposition is believed to be followed by tangle pathology and …

Read more

STUDIES ARE ENROLLING NOW!

MEMORY LOSS

For those who are struggling with memory loss, a memory screen is a step in the right direction to keeping their minds healthy. Apply for a FREE memory screen today!